5,000 patients join Yale's quest to crack rheumatic disease mysteries
NCT ID NCT04402086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is building a large registry and biorepository of 5,000 adults with various rheumatic diseases like rheumatoid arthritis, lupus, and scleroderma. Researchers at Yale University will collect medical data and biological samples over time to better understand these conditions and find links between outcomes and biomarkers. The goal is to support future research that could lead to improved diagnosis and treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could help researchers discover new biomarkers and improve understanding of rheumatic diseases, pointing toward better diagnostics or treatments.
- What could go wrong
- This is an observational registry, not a treatment trial. It may not directly lead to new therapies, and results depend on participant diversity and data quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADULT-ONSET STILL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Yale New Haven Hospital
RECRUITINGNew Haven, Connecticut, 06510, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a skin patch ease stomach pain in scleroderma?
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers